Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP02.03 - Early Stage Non-small Cell Lung Cancer - Surgery
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Surgery
-
+
EP02.03-009 - Real-world Disease-Free Survival as a Predictor of Overall Survival in Resected Early-Stage Non-Small Cell Lung Cancer
Presenter: Howard (Jack) West | Author(s): Xiaohan Hu, Diana Chirovsky, Yan Song, Su Zhang, Chi Gao, Christopher Carley, Ariel Lerner, James Signorovitch, Ayman Samkari- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-083 - Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
Presenter: Simon Ekman | Author(s): Gunnar Wagenius, Anders Vikström, Anders Berglund, Stina Salomonsson, Goran Bencina, Xiaohan Hu, Diana Chirovsky, Hans Brunnström- Abstract
Loading...
-
+
OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
- 11:00 - 12:00
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Moderators:Lubos Petruzelka, Pilar Garrido
-
+
OA07.04 - Overall Survival in Patients With Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet
11:12 - 11:22 | Presenter: Stephen V. Liu | Author(s): Xiaohan Hu, Diana Chirovsky, Weilin Meng, Ayman Samkari
- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Presenter: Delvys Rodriguez-Abreu | Author(s): Yi-Long Wu, Michael Boyer, Marina Chiara Garassino, Tony S. K. Mok, Ying Cheng, Rina Hui, Dariusz M. Kowalski, Andrew G. Robinson, Julie Brahmer, Ticiana Leal, Gilberto Lopes, Byoung Chul Cho, Naoyuki Nogami, Silvia Novello, Nir Peled, Gilberto de Castro, Melanie A. Leiby, Diana Chirovsky, Jianxin Lin, M. Catherine Pietanza, Martin Reck
- Abstract
Loading...
